ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
What needle length for IM TRT? Thinking of changing from subQ to IM to feel better
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 186005" data-attributes="member: 13851"><p>Depends on what area of the glute you are injecting.</p><p></p><p></p><p></p><p></p><p><strong>Effects of thickness of muscle and subcutaneous fat on efficacy of gluteal intramuscular injection sites </strong></p><p><strong></strong></p><p><strong></strong></p><p><strong>ABSTRACT </strong></p><p></p><p><em><span style="color: rgb(184, 49, 47)">Intramuscular injections given at the dorsogluteal and ventrogluteal sites are intended for the gluteus maximus and gluteus medius muscles, respectively.</span></em> However, little research has confirmed the reliability of these sites for the presence and thickness of the target and other muscles, and subcutaneous fat. This study characterized and compared these at the V-method and G-method ventrogluteal sites and dorsogluteal site (n=60). Gluteus maximus, medius and minimus were identified at each site, plus tensor fascia latae at ventrogluteal sites.<span style="color: rgb(184, 49, 47)"><em> <strong>Gluteus maximus and subcutaneous fat were significantly thicker and gluteus minimus significantly thinner at the dorsogluteal site</strong></em></span><strong> <span style="color: rgb(184, 49, 47)"><em>t<u>han both ventrogluteal sites</u>.</em></span> </strong><span style="color: rgb(44, 130, 201)"><em><strong>Gluteus medius was the thickest muscle at each injection site, and thicker at the G-method than the V-method ventrogluteal site. Therefore, the dorsogluteal site reliably targets gluteus maximus,</strong></em> </span><em><span style="color: rgb(44, 130, 201)"><strong>and the G-method ventrogluteal site was more reliable than the V-method ventrogluteal site to target gluteus medius in terms of presence and thickness. </strong></span></em></p><p></p><p></p><p></p><p></p><p><strong>KEY POINTS</strong></p><p></p><p>■ <span style="color: rgb(184, 49, 47)">Little research has confirmed the reliability of the gluteal intramuscular injection sites in terms of the presence or thickness of all the muscles and subcutaneous fat at these injection sites </span></p><p></p><p>■ <span style="color: rgb(184, 49, 47)">Gluteus maximus was present in 100% of cases at the dorsogluteal site, and was thicker at this site than the ventrogluteal sites; therefore, the dorsogluteal site reliably targets gluteus maximus </span></p><p></p><p>■ <span style="color: rgb(184, 49, 47)">Gluteus medius was present in 100% of cases and thicker at the G-method than the V-method ventrogluteal site; therefore, the G-method ventrogluteal site is more reliable than the V-method ventrogluteal site to target gluteus medius muscle </span></p><p></p><p>■ <span style="color: rgb(184, 49, 47)">The V-method ventrogluteal site is less reliable and more variable, with gluteus medius present in 95% of cases and tensor fascia latae muscle present unilaterally in 20% of participants </span></p><p></p><p>■ <span style="color: rgb(184, 49, 47)">An intended intramuscular injection given at the dorsogluteal site would be deposited in the subcutaneous fat or gluteus medius for 27% and 15% of participants, respectively </span></p><p></p><p></p><p></p><p></p><p></p><p></p><p><strong>Conclusion </strong></p><p></p><p><em><span style="color: rgb(184, 49, 47)">This study is the first to report on characterisation and comparison of the dorsogluteal and the two ventrogluteal intramuscular injection sites. Overall, the dorsogluteal site is reliable for targeting gluteus maximus and had a thicker muscle layer than both of the ventrogluteal sites. However, this site was also characterized by thicker subcutaneous fat and was associated with a higher risk of a subcutaneous, rather than intramuscular, injection.</span></em> <em><strong><span style="color: rgb(184, 49, 47)">Therefore, it is recommended that, particularly for females who are overweight or obese, the ventrogluteal site be used instead of the dorsogluteal site. </span></strong></em></p><p><em></em></p><p><em><span style="color: rgb(184, 49, 47)"><strong>The G-method ventrogluteal site is more reliable than the V-method ventrogluteal site in terms of gluteus medius presence, muscle thickness, and the likelihood of successful intramuscular injection.</strong></span></em> There was greater variability at the V-method ventrogluteal site, particularly in terms of muscles other than the target muscles, and more individuals were at risk of the needle reaching the bone here. Accordingly, it would be beneficial for nurses to become familiar with, and to practice, the G method of ventrogluteal site identification. The G method should be used over the V method for leaner individuals for a successful intramuscular injection without the risk of bone contact.</p><p></p><p><em><span style="color: rgb(44, 130, 201)"><strong>Overall, because of the significant influences of gender and BMI on subcutaneous fat thickness, these characteristics may be useful discriminators to assist with site selection and needle length for successful intramuscular injection outcomes. </strong></span></em>Nurses should base their site selection and needle size choices based on an assessment of patient characteristics, including gender and BMI. More research to support evidence-based decisions is warranted.</p></blockquote><p></p>
[QUOTE="madman, post: 186005, member: 13851"] Depends on what area of the glute you are injecting. [B]Effects of thickness of muscle and subcutaneous fat on efficacy of gluteal intramuscular injection sites ABSTRACT [/B] [I][COLOR=rgb(184, 49, 47)]Intramuscular injections given at the dorsogluteal and ventrogluteal sites are intended for the gluteus maximus and gluteus medius muscles, respectively.[/COLOR][/I] However, little research has confirmed the reliability of these sites for the presence and thickness of the target and other muscles, and subcutaneous fat. This study characterized and compared these at the V-method and G-method ventrogluteal sites and dorsogluteal site (n=60). Gluteus maximus, medius and minimus were identified at each site, plus tensor fascia latae at ventrogluteal sites.[COLOR=rgb(184, 49, 47)][I] [B]Gluteus maximus and subcutaneous fat were significantly thicker and gluteus minimus significantly thinner at the dorsogluteal site[/B][/I][/COLOR][B] [COLOR=rgb(184, 49, 47)][I]t[U]han both ventrogluteal sites[/U].[/I][/COLOR] [/B][COLOR=rgb(44, 130, 201)][I][B]Gluteus medius was the thickest muscle at each injection site, and thicker at the G-method than the V-method ventrogluteal site. Therefore, the dorsogluteal site reliably targets gluteus maximus,[/B][/I] [/COLOR][I][COLOR=rgb(44, 130, 201)][B]and the G-method ventrogluteal site was more reliable than the V-method ventrogluteal site to target gluteus medius in terms of presence and thickness. [/B][/COLOR][/I] [B]KEY POINTS[/B] ■ [COLOR=rgb(184, 49, 47)]Little research has confirmed the reliability of the gluteal intramuscular injection sites in terms of the presence or thickness of all the muscles and subcutaneous fat at these injection sites [/COLOR] ■ [COLOR=rgb(184, 49, 47)]Gluteus maximus was present in 100% of cases at the dorsogluteal site, and was thicker at this site than the ventrogluteal sites; therefore, the dorsogluteal site reliably targets gluteus maximus [/COLOR] ■ [COLOR=rgb(184, 49, 47)]Gluteus medius was present in 100% of cases and thicker at the G-method than the V-method ventrogluteal site; therefore, the G-method ventrogluteal site is more reliable than the V-method ventrogluteal site to target gluteus medius muscle [/COLOR] ■ [COLOR=rgb(184, 49, 47)]The V-method ventrogluteal site is less reliable and more variable, with gluteus medius present in 95% of cases and tensor fascia latae muscle present unilaterally in 20% of participants [/COLOR] ■ [COLOR=rgb(184, 49, 47)]An intended intramuscular injection given at the dorsogluteal site would be deposited in the subcutaneous fat or gluteus medius for 27% and 15% of participants, respectively [/COLOR] [B]Conclusion [/B] [I][COLOR=rgb(184, 49, 47)]This study is the first to report on characterisation and comparison of the dorsogluteal and the two ventrogluteal intramuscular injection sites. Overall, the dorsogluteal site is reliable for targeting gluteus maximus and had a thicker muscle layer than both of the ventrogluteal sites. However, this site was also characterized by thicker subcutaneous fat and was associated with a higher risk of a subcutaneous, rather than intramuscular, injection.[/COLOR][/I] [I][B][COLOR=rgb(184, 49, 47)]Therefore, it is recommended that, particularly for females who are overweight or obese, the ventrogluteal site be used instead of the dorsogluteal site. [/COLOR][/B] [COLOR=rgb(184, 49, 47)][B]The G-method ventrogluteal site is more reliable than the V-method ventrogluteal site in terms of gluteus medius presence, muscle thickness, and the likelihood of successful intramuscular injection.[/B][/COLOR][/I] There was greater variability at the V-method ventrogluteal site, particularly in terms of muscles other than the target muscles, and more individuals were at risk of the needle reaching the bone here. Accordingly, it would be beneficial for nurses to become familiar with, and to practice, the G method of ventrogluteal site identification. The G method should be used over the V method for leaner individuals for a successful intramuscular injection without the risk of bone contact. [I][COLOR=rgb(44, 130, 201)][B]Overall, because of the significant influences of gender and BMI on subcutaneous fat thickness, these characteristics may be useful discriminators to assist with site selection and needle length for successful intramuscular injection outcomes. [/B][/COLOR][/I]Nurses should base their site selection and needle size choices based on an assessment of patient characteristics, including gender and BMI. More research to support evidence-based decisions is warranted. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
What needle length for IM TRT? Thinking of changing from subQ to IM to feel better
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top